DAO has been shown to reduce NMDAR-mediated neurotransmission (Mothet et al., 2000) and thus increased DAO in schizophrenia might contribute, via d-serine decrements, to NMDAR dysfunction. The gene discussed is DAO; the disease is schizophrenia.